Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Titel:
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Auteur:
Tahara, Makoto Greil, Richard Rischin, Danny Harrington, Kevin J. Burtness, Barbara de Castro, Gilberto Psyrri, Amanda Braña, Irene Neupane, Prakash Bratland, Åse Fuereder, Thorsten Hughes, Brett G.M. Mesía, Ricard Ngamphaiboon, Nuttapong Rordorf, Tamara Ishak, Wan Zamaniah Wan Lin, Jianxin Gumuscu, Burak Lerman, Nati Soulières, Denis